Universe Pharmaceuticals INC (UPC)
USD 4.73
(-3.07%)
USD 4.73
(-3.07%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 53.28 Million USD | -10.5% |
| 2022 | 59.53 Million USD | -15.12% |
| 2021 | 70.14 Million USD | 143.52% |
| 2020 | 28.8 Million USD | 61.49% |
| 2019 | 17.83 Million USD | -36.48% |
| 2018 | 28.07 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 49.43 Million USD | 0.0% |
| 2023 FY | 53.28 Million USD | -10.5% |
| 2023 Q4 | 53.28 Million USD | 0.0% |
| 2023 Q2 | 70.36 Million USD | 0.0% |
| 2022 FY | 59.53 Million USD | -15.12% |
| 2022 Q4 | 59.53 Million USD | 0.0% |
| 2022 Q2 | 71.36 Million USD | 0.0% |
| 2021 Q2 | 67.27 Million USD | 0.0% |
| 2021 FY | 70.14 Million USD | 143.52% |
| 2021 Q4 | 70.14 Million USD | 0.0% |
| 2020 FY | 28.8 Million USD | 61.49% |
| 2020 Q4 | 28.8 Million USD | 0.0% |
| 2020 Q2 | 26.77 Million USD | 0.0% |
| 2019 FY | 17.83 Million USD | -36.48% |
| 2019 Q4 | 17.83 Million USD | 0.0% |
| 2018 FY | 28.07 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | 94.108% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | 7.195% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | 95.339% |
| Cosmos Health Inc. | 66.29 Million USD | 19.622% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -302.241% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | 74.107% |
| Cronos Group Inc. | 1.13 Billion USD | 95.302% |
| Incannex Healthcare Limited | 17.04 Million USD | -212.589% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | 4.758% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | 80.531% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -531.497% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -94.855% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -94.855% |
| SCYNEXIS, Inc. | 128.41 Million USD | 58.503% |
| Safety Shot Inc | 12.7 Million USD | -319.28% |
| Theratechnologies Inc. | 77.76 Million USD | 31.48% |
| Alpha Teknova, Inc. | 128.58 Million USD | 58.56% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | 96.615% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -257.799% |
| Dynavax Technologies Corporation | 997.09 Million USD | 94.656% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | 88.688% |
| Radius Health, Inc. | 1.71 Billion USD | 96.895% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | -130.41% |
| Alvotech | 950.09 Million USD | 94.391% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | 92.683% |
| SIGA Technologies, Inc. | 254.83 Million USD | 79.09% |
| Shineco, Inc. | 84.17 Million USD | 36.698% |
| Silver Spike Investment Corp. | 88.57 Million USD | 39.841% |
| Journey Medical Corporation | 76.84 Million USD | 30.66% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | -57.674% |
| Embecta Corp. | 1.21 Billion USD | 95.612% |
| Harrow Health, Inc. | 311.75 Million USD | 82.907% |
| Procaps Group, S.A. | 460.18 Million USD | 88.421% |
| Biofrontera Inc. | 27.93 Million USD | -90.774% |
| DURECT Corporation | 45.18 Million USD | -17.92% |
| PainReform Ltd. | 9.93 Million USD | -436.627% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | 96.218% |
| OptiNose, Inc. | 107.72 Million USD | 50.536% |
| RedHill Biopharma Ltd. | 23.04 Million USD | -131.209% |
| Organogenesis Holdings Inc. | 460.02 Million USD | 88.416% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | 34.838% |
| ProPhase Labs, Inc. | 91.92 Million USD | 42.033% |
| Phibro Animal Health Corporation | 982.18 Million USD | 94.575% |
| Procaps Group S.A. | 460.18 Million USD | 88.421% |
| TherapeuticsMD, Inc. | 43.3 Million USD | -23.039% |
| Viatris Inc. | 47.68 Billion USD | 99.888% |
| Rockwell Medical, Inc. | 52.17 Million USD | -2.135% |
| Aytu BioPharma, Inc. | 118.09 Million USD | 54.878% |
| Tilray Brands, Inc. | 4.33 Billion USD | 98.771% |
| PetIQ, Inc. | 868.22 Million USD | 93.863% |
| Talphera, Inc. | 20.39 Million USD | -161.275% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 98.361% |
| Alimera Sciences, Inc. | 153.52 Million USD | 65.291% |
| Assertio Holdings, Inc. | 286.41 Million USD | 81.395% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -795.319% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | 79.593% |
| Hempacco Co., Inc. | 18.04 Million USD | -195.332% |
| Alvotech | 950.09 Million USD | 94.391% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | 96.773% |
| Kamada Ltd. | 351.96 Million USD | 84.86% |
| Currenc Group, Inc. | 141.49 Million USD | 62.339% |
| Indivior PLC | 1.95 Billion USD | 97.269% |
| Evoke Pharma, Inc. | 7.06 Million USD | -653.861% |
| Flora Growth Corp. | 23.62 Million USD | -125.544% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -302.241% |
| Evolus, Inc. | 188.99 Million USD | 71.806% |
| HUTCHMED (China) Limited | 1.27 Billion USD | 95.836% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | 96.478% |
| Akanda Corp. | 8.83 Million USD | -502.795% |